Herbalife (HLF) has a market cap of $5.8 billion. It fell by 2.3% to close at $60.5 per share on August 26, 2016. The stock’s weekly, monthly, and YTD (year-to-date) price movements were -4.4%, -9.7%, and 12.8%, respectively, on the same day.
HLF is trading 7.4% below its 20-day moving average, 3.9% below its 50-day moving average, and 5.4% above its 200-day moving average.
Related ETFs and peers
The PowerShares Dynamic Market Portfolio ETF (PWC) invests 0.55% of its holdings in Herbalife. The ETF tracks a quant-selected, tier-weighted index covering the entire US equity market. The YTD price movement of PWC was 1.9% on August 26.
The iShares Russell 3000 ETF (IWV) invests 0.02% of its holdings in Herbalife. The ETF tracks a cap-weighted index that measures the investable US equities market, covering the entire market-cap spectrum, including micro-caps.
The market caps of Herbalife’s competitors are as follows:
Latest news on Herbalife
In a press release on August 26, 2016, Reuters reported, “Herbalife Ltd’s biggest critic, hedge fund manager Bill Ackman, said he had been approached to buy shares in the nutritional supplements maker from billionaire investor Carl Icahn.” The release added that “Ackman, who has bet more than $1 billion against Herbalife, said on CNBC that Icahn’s planned stake sale would accelerate the company’s downfall.”
In another press release, Reuters reported, “Carl Icahn said he did not attempt to sell his Herbalife Ltd (HLF) stake, and had instead bought more shares in the health supplements maker, rejecting hedge fund manager Bill Ackman’s claim that he had been offered some of Icahn’s shares.” The report added that “Herbalife shares rose 4 percent in extending trading, reversing course after Icahn said he had bought 2.3 million shares on Friday.”
Performance in 2Q16
Herbalife reported 2Q16 net sales of $1.2 billion—a rise of 3.4% as compared to net sales of $1.16 billion in 2Q15. Its sales in North America, EMEA (Europe, the Middle East, and Africa), and China rose by 15.9%, 13.0%, and 2.5%, respectively. Its sales in Mexico, South and Central America, and the Asia-Pacific region fell by 7.7%, 10.2%, and 1.9%, respectively, in 2Q16, as compared to the same period the previous year.
Its net income and EPS (earnings per share) fell to -$22.9 million and -$0.28, respectively, in 2Q16, as compared to $82.8 million and $0.97, respectively, in 2Q15. It reported adjusted EPS of $1.29 in 2Q16—a rise of 4.0% over 2Q15.
Herbalife’s cash and cash equivalents rose by 5.3%, and its inventories fell by 2.9% in 2Q16, as compared to 4Q15. Its current ratio fell to 1.1x in 2Q16, as compared to 1.5x in 4Q15.
The company made the following projections for 3Q16:
- volume point growth of 5.0%–8.0%
- net sales growth of 2.0%–5.0%
- adjusted EPS of $0.98–$1.08
- capital expenditure of $35.0 million–$45.0 million
- currency adjusted net sales growth of 5.5%–8.5%
- currency adjusted EPS of $1.12–$1.22
The company’s adjusted EPS guidance includes a projected unfavorable impact from currency exchange rates of ~$0.14 per share.
The company made the following projections for 2016:
- volume point growth of 4.5%–7.5%
- net sales growth of 1.5%–4.5%
- adjusted EPS of $4.50–$4.80
- capital expenditure of $160 million–$180 million
- effective tax rate of 27.5%–29.5%
- currency adjusted net sales growth of 7%–10%
- currency adjusted EPS of $5.4–$5.7
The adjusted EPS guidance includes a projected currency headwind of ~$0.90 per share.
Now we’ll look at Monro Muffler Brake (MNRO).